{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T10:39:18Z","timestamp":1781606358818,"version":"3.54.5"},"reference-count":91,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2017.00099","type":"journal-article","created":{"date-parts":[[2017,2,28]],"date-time":"2017-02-28T03:37:43Z","timestamp":1488253063000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["Protein-Remodeling Factors As Potential Therapeutics for Neurodegenerative Disease"],"prefix":"10.3389","volume":"11","author":[{"given":"Meredith E.","family":"Jackrel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Shorter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,2,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.biopsych.2013.02.027","article-title":"Allosteric heat shock protein 70 inhibitors rapidly rescue synaptic plasticity deficits by reducing aberrant tau","volume":"74","author":"Abisambra","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e1002472","DOI":"10.1371\/journal.pbio.1002472","article-title":"NMNAT2:HSP90 complex mediates proteostasis in proteinopathies","volume":"14","author":"Ali","year":"2016","journal-title":"PLoS Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/joim.12506","article-title":"Current and future treatment of amyloid diseases","volume":"280","author":"Ankarcrona","year":"2016","journal-title":"J. Intern. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jmb.2010.03.060","article-title":"Directed evolution of the DnaK chaperone: mutations in the lid domain result in enhanced chaperone activity","volume":"399","author":"Aponte","year":"2010","journal-title":"J. Mol. Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"5103","DOI":"10.1021\/acs.biochem.5b00459","article-title":"A rational design strategy for the selective activity enhancement of a molecular chaperone toward a target substrate","volume":"54","author":"Aprile","year":"2015","journal-title":"Biochemistry"},{"key":"B6","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1126\/science.1067389","article-title":"Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease","volume":"295","author":"Auluck","year":"2002","journal-title":"Science"},{"key":"B7","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1126\/science.1141448","article-title":"Adapting proteostasis for disease intervention","volume":"319","author":"Balch","year":"2008","journal-title":"Science"},{"key":"B8","doi-asserted-by":"publisher","first-page":"9629","DOI":"10.1073\/pnas.1121005109","article-title":"Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade","volume":"109","author":"Bulawa","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nrneurol.2010.18","article-title":"TAR DNA-binding protein 43 in neurodegenerative disease","volume":"6","author":"Chen-Plotkin","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"B10","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1126\/science.7754373","article-title":"Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]","volume":"268","author":"Chernoff","year":"1995","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3109\/13506129.2015.1063485","article-title":"Personalized medicine approach for optimizing the dose of tafamidis to potentially ameliorate wild-type transthyretin amyloidosis (cardiomyopathy)","volume":"22","author":"Cho","year":"2015","journal-title":"Amyloid"},{"issue":"Pt 8","key":"B12","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1242\/jcs.051672","article-title":"Prion-like disorders: blurring the divide between transmissibility and infectivity","volume":"123","author":"Cushman","year":"2010","journal-title":"J. Cell Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e1003781","DOI":"10.1371\/journal.pgen.1003781","article-title":"Hsp104 suppresses polyglutamine-induced degeneration post onset in a drosophila MJD\/SCA3 model","volume":"9","author":"Cushman-Nick","year":"2013","journal-title":"PLoS Genet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S1474-4422(15)00006-X","article-title":"Targeting alpha-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations","volume":"14","author":"Dehay","year":"2015","journal-title":"Lancet Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.cell.2012.09.038","article-title":"Operational plasticity enables hsp104 to disaggregate diverse amyloid and nonamyloid clients","volume":"151","author":"DeSantis","year":"2012","journal-title":"Cell"},{"key":"B16","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/nature02261","article-title":"Protein folding and misfolding","volume":"426","author":"Dobson","year":"2003","journal-title":"Nature"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e1001346","DOI":"10.1371\/journal.pbio.1001346","article-title":"Small heat shock proteins potentiate amyloid dissolution by protein disaggregases from yeast and humans","volume":"10","author":"Duennwald","year":"2012","journal-title":"PLoS Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.4161\/auto.8.2.18938","article-title":"Alpha-synuclein's degradation in vivo: opening a new (cranial) window on the roles of degradation pathways in Parkinson disease","volume":"8","author":"Ebrahimi-Fakhari","year":"2012","journal-title":"Autophagy"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nature09320","article-title":"Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS","volume":"466","author":"Elden","year":"2010","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e0117192","DOI":"10.1371\/journal.pone.0117192","article-title":"Metabolic and chaperone gene loss marks the origin of animals: evidence for Hsp104 and Hsp78 chaperones sharing mitochondrial enzymes as clients","volume":"10","author":"Erives","year":"2015","journal-title":"PLoS ONE"},{"key":"B21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3389\/fmolb.2015.00029","article-title":"Multi-layered molecular mechanisms of polypeptide holding, unfolding and disaggregation by HSP70\/HSP110 chaperones","volume":"2","author":"Finka","year":"2015","journal-title":"Front. Mol. Biosci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1093\/hmg\/ddv135","article-title":"The active Hsc70\/tau complex can be exploited to enhance tau turnover without damaging microtubule dynamics","volume":"24","author":"Fontaine","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/nm1113","article-title":"Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs","volume":"10","author":"Forman","year":"2004","journal-title":"Nat. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.molcel.2015.07.012","article-title":"Human Hsp70 disaggregase reverses Parkinson's-linked alpha-synuclein amyloid fibrils","volume":"59","author":"Gao","year":"2015","journal-title":"Mol. Cell"},{"key":"B25","doi-asserted-by":"publisher","first-page":"170426","DOI":"10.1155\/2012\/170426","article-title":"Administration of recombinant heat shock protein 70 delays peripheral muscle denervation in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis","volume":"2012","author":"Gifondorwa","year":"2012","journal-title":"Neurol. Res. Int."},{"key":"B26","doi-asserted-by":"publisher","first-page":"13173","DOI":"10.1523\/JNEUROSCI.4057-07.2007","article-title":"Exogenous delivery of heat shock protein 70 increases lifespan in a mouse model of amyotrophic lateral sclerosis","volume":"27","author":"Gifondorwa","year":"2007","journal-title":"J. Neurosci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e1000300","DOI":"10.1371\/journal.pbio.1000300","article-title":"Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons","volume":"8","author":"Gilley","year":"2010","journal-title":"PLoS Biol."},{"key":"B28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0092-8674(00)81223-4","article-title":"Hsp104, Hsp70, and Hsp40: a novel chaperone system that rescues previously aggregated proteins","volume":"94","author":"Glover","year":"1998","journal-title":"Cell"},{"key":"B29","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1139\/bcb-79-5-557","article-title":"Crowbars and ratchets: hsp100 chaperones as tools in reversing protein aggregation","volume":"79","author":"Glover","year":"2001","journal-title":"Biochem. Cell Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1242\/dmm.016113","article-title":"Potentiated Hsp104 variants suppress toxicity of diverse neurodegenerative disease-linked proteins","volume":"7","author":"Jackrel","year":"2014a","journal-title":"Dis. Model. Mech."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.4161\/cc.28709","article-title":"Reversing deleterious protein aggregation with re-engineered protein disaggregases","volume":"13","author":"Jackrel","year":"2014b","journal-title":"Cell Cycle"},{"key":"B32","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1080\/19336896.2015.1020277","article-title":"Engineering enhanced protein disaggregases for neurodegenerative disease","volume":"9","author":"Jackrel","year":"2015","journal-title":"Prion"},{"key":"B33","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.cell.2013.11.047","article-title":"Potentiated Hsp104 Variants antagonize diverse proteotoxic misfolding events","volume":"156","author":"Jackrel","year":"2014a","journal-title":"Cell"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e52089","DOI":"10.3791\/52089","article-title":"Isolating potentiated Hsp104 variants using yeast proteinopathy models","volume":"93","author":"Jackrel","year":"2014b","journal-title":"J. Vis. Exp."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1021\/acschembio.5b00765","article-title":"Disparate mutations confer therapeutic gain of Hsp104 function","volume":"10","author":"Jackrel","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e115362","DOI":"10.1371\/journal.pone.0115362","article-title":"Protoporphyrins enhance oligomerization and enzymatic activity of HtrA1 serine protease","volume":"9","author":"Jo","year":"2014","journal-title":"PLoS ONE"},{"key":"B37","doi-asserted-by":"publisher","first-page":"6439","DOI":"10.1073\/pnas.0802082105","article-title":"A yeast TDP-43 proteinopathy model: exploring the molecular determinants of TDP-43 aggregation and cellular toxicity","volume":"105","author":"Johnson","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e1001052","DOI":"10.1371\/journal.pbio.1001052","article-title":"A yeast model of FUS\/TLS-dependent cytotoxicity","volume":"9","author":"Ju","year":"2011","journal-title":"PLoS Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e833","DOI":"10.1038\/cddis.2013.351","article-title":"Suppression of polyglutamine protein toxicity by co-expression of a heat-shock protein 40 and a heat-shock protein 110","volume":"4","author":"Kuo","year":"2013","journal-title":"Cell Death Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"R46","DOI":"10.1093\/hmg\/ddq137","article-title":"TDP-43 and FUS\/TLS: emerging roles in RNA processing and neurodegeneration","volume":"19","author":"Lagier-Tourenne","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"B41","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.biocel.2011.01.022","article-title":"Heat shock protein 104 inhibited the fibrillization of prion peptide 106-126 and disassembled prion peptide 106-126 fibrils in vitro","volume":"43","author":"Liu","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/hmg\/ddr492","article-title":"CREB-activity and nmnat2 transcription are down-regulated prior to neurodegeneration, while NMNAT2 over-expression is neuroprotective, in a mouse model of human tauopathy","volume":"21","author":"Ljungberg","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"B43","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1172\/JCI35781","article-title":"Hsp104 antagonizes alpha-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease","volume":"118","author":"Lo Bianco","year":"2008","journal-title":"J. Clin. Invest."},{"key":"B44","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fmolb.2016.00008","article-title":"Engineering and evolution of molecular chaperones and protein disaggregases with enhanced activity","volume":"3","author":"Mack","year":"2016","journal-title":"Front. Mol. Biosci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S1474-4422(10)70195-2","article-title":"TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia","volume":"9","author":"Mackenzie","year":"2010","journal-title":"Lancet Neurol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1126\/science.aac9145","article-title":"Pharmacological chaperone for alpha-crystallin partially restores transparency in cataract models","volume":"350","author":"Makley","year":"2015","journal-title":"Science"},{"key":"B47","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nature20137","article-title":"Alternative modes of client binding enable functional plasticity of Hsp70","volume":"539","author":"Mashaghi","year":"2016","journal-title":"Nature"},{"key":"B48","doi-asserted-by":"publisher","first-page":"21399","DOI":"10.1074\/jbc.M113.479253","article-title":"Hsp110 is a bona fide chaperone using ATP to unfold stable misfolded polypeptides and reciprocally collaborate with Hsp70 to solubilize protein aggregates","volume":"288","author":"Mattoo","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B49","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1007\/s00018-004-4464-6","article-title":"Hsp70 chaperones: cellular functions and molecular mechanism","volume":"62","author":"Mayer","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1021\/cn300210g","article-title":"Synthesis and initial evaluation of YM-08, a blood-brain barrier permeable derivative of the heat shock protein 70 (Hsp70) inhibitor MKT-077, which reduces tau levels","volume":"4","author":"Miyata","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1056\/NEJMcibr065573","article-title":"Stress, aging, and neurodegenerative disease","volume":"355","author":"Morimoto","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"5424","DOI":"10.1073\/pnas.1604885113","article-title":"Extended survival of misfolded G85R SOD1-linked ALS mice by transgenic expression of chaperone Hsp110","volume":"113","author":"Nagy","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B53","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"B54","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.tcb.2013.01.007","article-title":"Blessings in disguise: biological benefits of prion-like mechanisms","volume":"23","author":"Newby","year":"2013","journal-title":"Trends Cell Biol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fmolb.2015.00057","article-title":"Metazoan Hsp70-based protein disaggregases: emergence and mechanisms","volume":"2","author":"Nillegoda","year":"2015","journal-title":"Front. Mol. Biosci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature14884","article-title":"Crucial HSP70 co-chaperone complex unlocks metazoan protein disaggregation","volume":"524","author":"Nillegoda","year":"2015","journal-title":"Nature"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1126\/science.aaf1064","article-title":"C9orf72 is required for proper macrophage and microglial function in mice","volume":"351","author":"O'Rourke","year":"2016","journal-title":"Science"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1126\/science.1090439","article-title":"Yeast cells provide insight into alpha-synuclein biology and pathobiology","volume":"302","author":"Outeiro","year":"2003","journal-title":"Science"},{"key":"B59","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/372475a0","article-title":"Protein disaggregation mediated by heat-shock protein Hsp104","volume":"372","author":"Parsell","year":"1994","journal-title":"Nature"},{"key":"B60","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/353270a0","article-title":"Hsp104 is a highly conserved protein with two essential nucleotide-binding sites","volume":"353","author":"Parsell","year":"1991","journal-title":"Nature"},{"key":"B61","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nchembio.1931","article-title":"Determinants of amyloid fibril degradation by the PDZ protease HTRA1","volume":"11","author":"Poepsel","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nrn3430","article-title":"The changing scene of amyotrophic lateral sclerosis","volume":"14","author":"Robberecht","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"B63","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.jmb.2011.06.003","article-title":"Allosteric drugs: the interaction of antitumor compound MKT-077 with human Hsp70 chaperones","volume":"411","author":"Rousaki","year":"2011","journal-title":"J. Mol. Biol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.111.078915","article-title":"Transthyretin (TTR) cardiac amyloidosis","volume":"126","author":"Ruberg","year":"2012","journal-title":"Circulation"},{"key":"B65","doi-asserted-by":"publisher","first-page":"10787","DOI":"10.1038\/ncomms10787","article-title":"Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity","volume":"7","author":"Sant'Anna","year":"2016","journal-title":"Nat. Commun."},{"key":"B66","doi-asserted-by":"publisher","first-page":"5750","DOI":"10.1073\/pnas.100107297","article-title":"Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans","volume":"97","author":"Satyal","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B67","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neuron.2011.06.031","article-title":"Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration","volume":"71","author":"Saxena","year":"2011","journal-title":"Neuron"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1002\/cbic.201000786","article-title":"Fine tuning of a biological machine: DnaK gains improved chaperone activity by altered allosteric communication and substrate binding","volume":"12","author":"Schweizer","year":"2011","journal-title":"Chembiochem"},{"key":"B69","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces Abeta plaques in Alzheimer's disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"B70","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000109760","article-title":"Hsp104: a weapon to combat diverse neurodegenerative disorders","volume":"16","author":"Shorter","year":"2008","journal-title":"Neurosignals"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e26319","DOI":"10.1371\/journal.pone.0026319","article-title":"The mammalian disaggregase machinery: Hsp110 synergizes with Hsp70 and Hsp40 to catalyze protein disaggregation and reactivation in a cell-free system","volume":"6","author":"Shorter","year":"2011","journal-title":"PLoS ONE"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1091\/mbc.E15-10-0693","article-title":"Engineering therapeutic protein disaggregases","volume":"27","author":"Shorter","year":"2016","journal-title":"Mol. Biol. Cell"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1126\/science.1098007","article-title":"Hsp104 catalyzes formation and elimination of self-replicating Sup35 prion conformers","volume":"304","author":"Shorter","year":"2004","journal-title":"Science"},{"key":"B74","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrg1616","article-title":"Prions as adaptive conduits of memory and inheritance","volume":"6","author":"Shorter","year":"2005","journal-title":"Nat. Rev. Genet."},{"key":"B75","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.molcel.2006.05.042","article-title":"Destruction or potentiation of different prions catalyzed by similar Hsp104 remodeling activities","volume":"23","author":"Shorter","year":"2006","journal-title":"Mol. Cell"},{"key":"B76","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"B77","doi-asserted-by":"publisher","first-page":"e1000614","DOI":"10.1371\/journal.pbio.1000614","article-title":"Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS\/TLS","volume":"9","author":"Sun","year":"2011","journal-title":"PLoS Biol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4161\/pri.2.4.7952","article-title":"Prion proteostasis: Hsp104 meets its supporting cast","volume":"2","author":"Sweeny","year":"2008","journal-title":"Prion"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1016\/j.jmb.2015.11.016","article-title":"Mechanistic and structural insights into the prion-disaggregase activity of Hsp104","volume":"428","author":"Sweeny","year":"2016","journal-title":"J. Mol. Biol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.molcel.2014.12.021","article-title":"The Hsp104 N-terminal domain enables disaggregase plasticity and potentiation","volume":"57","author":"Sweeny","year":"2015","journal-title":"Mol. Cell"},{"key":"B81","doi-asserted-by":"publisher","first-page":"457","DOI":"10.4161\/pri.27531","article-title":"The metazoan protein disaggregase and amyloid depolymerase system: Hsp110, Hsp70, Hsp40, and small heat shock proteins","volume":"7","author":"Torrente","year":"2013","journal-title":"Prion"},{"key":"B82","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.1093\/hmg\/ddi372","article-title":"Overexpression of yeast hsp104 reduces polyglutamine aggregation and prolongs survival of a transgenic mouse model of Huntington's disease","volume":"14","author":"Vacher","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.cell.2015.08.041","article-title":"Reversible, specific, active aggregates of endogenous proteins assemble upon heat stress","volume":"162","author":"Wallace","year":"2015","journal-title":"Cell"},{"key":"B84","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nchembio.1140","article-title":"Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation","volume":"9","author":"Wang","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/70532","article-title":"Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70","volume":"23","author":"Warrick","year":"1999","journal-title":"Nat. Genet."},{"key":"B86","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0092-8674(00)81200-3","article-title":"Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila","volume":"93","author":"Warrick","year":"1998","journal-title":"Cell"},{"key":"B87","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/sj.emboj.7601930","article-title":"The two faces of protein misfolding: gain- and loss-of-function in neurodegenerative diseases","volume":"27","author":"Winklhofer","year":"2008","journal-title":"EMBO J."},{"key":"B88","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","article-title":"Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease","volume":"101","author":"Yamamoto","year":"2000","journal-title":"Cell"},{"key":"B89","doi-asserted-by":"publisher","first-page":"E1121","DOI":"10.1073\/pnas.1322641111","article-title":"Partial loss of TDP-43 function causes phenotypes of amyotrophic lateral sclerosis","volume":"111","author":"Yang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B90","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/nsmb.3277","article-title":"Spiral architecture of the Hsp104 disaggregase reveals the basis for polypeptide translocation","volume":"23","author":"Yokom","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nature06721","article-title":"NAD synthase NMNAT acts as a chaperone to protect against neurodegeneration","volume":"452","author":"Zhai","year":"2008","journal-title":"Nature"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnins.2017.00099\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T11:31:10Z","timestamp":1498390270000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnins.2017.00099\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,28]]},"references-count":91,"URL":"https:\/\/doi.org\/10.3389\/fnins.2017.00099","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,28]]}}}